Výsledky vyhledávání - "G. Genestreti"

It could suddenly happen: delayed rupture of the trachea after total thyroidectomy. A case report

Autor: S, Sanna, M, Monteverde, M, Taurchini, M, Mengozzi, G, Genestreti, W, Grossi, D, Argnani, D, Bettini, D, Dell'Amore

Publikováno v: Il Giornale di chirurgia. 35(3-4)

We report the case of a patient who presented with subcutaneous emphysema, dyspnea and cough 7 days after total thyroidectomy for cancer. In addition we review the Literature and discuss the therapeutic challenges as well as management options.A 17-y

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0c61ad98ef6befc93dbfbc054300bf60
https://pubmed.ncbi.nlm.nih.gov/24841680

Zobrazit plný text záznamu

Survival following complete resection of multifocal T4 node-negative NSCLC: a retrospective study

Autor: Alberto Terzi, Antonio Santo, Birgit Feil, C. Benato, G. Genestreti, G. Falezza, S. Furia, Francesco Calabrò

Publikováno v: The Thoracic and cardiovascular surgeon. 55(1)

Background Multifocal NSCLC in the same lobe are staged as T4. This study was designed to assess the impact of multifocal NSCLC in the same lobe on survival in completely resected node-negative patients to determine whether the T4 (stage III B) desig

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d1bd5fd4fc23e62904ea4cb028d4a4c
https://pubmed.ncbi.nlm.nih.gov/17285473

Zobrazit plný text záznamu

Small cell lung cancer

Autor: Antonio Santo, G. Rosti, G. Bevilacqua, G. Genestreti, P. Bidoli, L. Portalone

Small cell lung cancer accounts for 13-15% of all lung cancer worldwide. There has been a decrease in the number of cases, with no clear explanation, except probably to changing in smoking habits in the last two decades. In the early eighties, it bec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88fe0e8a43026e8d4862bff6bb5e462d
http://hdl.handle.net/10281/260479

Zobrazit plný text záznamu

Multicenter Institutional Experience of Surgically Resected Thymic Epithelial Tumors (TETS): an Observational Report on Behalf of F.O.N.I.C.A.P. (Forza Operativa Nazionale Interdisciplinare Contro Il Cancro Del Polmone)

Autor: Marco Angelo Burgio, Antonio Santo, G. Genestreti, S. Sanna, Luca Ampollini, A. Verlicchi, Giampaolo Gavelli, Roberta Buosi, Manlio Monti, M. Mezzetti

Publikováno v: Annals of Oncology. 23:ix496-ix497

Purpose thymic epithelial tumors (TETs) are a rare neoplasms. Due to their rarity, large-scale prospective trials are lacking. The present retrospective multicenter analysis aimed to evaluate clinical outcome and clinical-pathological features of TET

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8960c1778630daeabfdaf962f11ad5a5
https://doi.org/10.1016/s0923-7534(20)34081-3

Zobrazit plný text záznamu

Phase II Study of Amrubicin in Patients with Refractory or Resistant Relapsed Small-Cell Lung Cancer: Japan Clinical Oncology Group Study (JCOG0901)

Autor: Masaharu Nishimura, G. Galffy, Q. Cheng, N. Stjepanovic, B. B. Oven Ustaalioglu, M.A. Damiano, G. Sajjady, J. Cai, B. Wallin, J. Dimitroulis, M. Reck, Judit Kocsis, B. Dome, S. Mellor, Y. Okuma, G. Le Teuff, N. Muzzafar, S. Yang, T. Tamura, S.A. Kazmi, G. Fust, H. Isobe, L. Graf, R. Eckert, D. Easty, S. Ahn, M. Chacon, D.A. Fennell, H. Daga, D. Pérez-Callejo, Raffaele Califano, Y. Ohe, Angela C. Casbard, Pablo Martinez, Y. Hosomi, H. Murakami, M. Salcedo, Y-C. Kim, Mustafa Canhoroz, Y. Fujita, A. Verlicchi, I. Oh, M.A. Burgio, S. Imtiaz, C. Kurkjian, M.A. Montero, A. Rosales, D. Pérez Callejo, C. Park, P. Ibeas, Susana Cedres, S. Heavey, Thierry Jahan, X. Wang, K. Kim, G. Stathopoulos, W. Sterlacci, M. Palka, N.B. Leighl, Satoshi Oizumi, Benjamin Besse, E. Almagro Casado, G. Gavelli, M. Yomoda, K. Takamura, C. Maximiano, J.W. Heyburn, Selcuk Seber, C. Lou, Wolfgang Hilbe, L. Tamasi, W. Mao, L. Ampollini, A. Santo, Jason F. Lester, D. Simos, H. Yang, J-C. Soria, H. Jamnig, S. Kuom, H. Ban, S. Sanna, Gareth Griffiths, Y. Ichinose, K. Na, D. Tsavdaridis, Taner Korkmaz, Z. Segota, R. Buosi, Lisette Sheena Nixon, G. Pall, K.A. Gately, M. Leschke, C. Martin, T. Schmid, P. Godwin, Hirotoshi Dosaka-Akita, M.E. Guiterrez, L. Lei, J. Edwards, C. Ho, Z. Prohaszka, David Planchard, H. Lu, Athanassios Argiris, J. Qin, M. Nevinny, Yvonne Summers, Y. Takagi, M. Endo, K.J. O'Byrne, T. Okamura, Z. Orosz, B. Cantos, A. Martinez, A. Falco, M. Mezzetti, E. Flechter, H. Watanabe, Umut Kefeli, G. Zangerl, M.S. Liew, R. Hassan, Serdar Turhal, A.C. Mita, I.A. Muazzam, Z. Bartfai, D. Nonaka, O.S. Breathnach, M. Monti, Harvey I. Pass, C. Poleri, O. Balvan, S. White, L. Mutti, J. Margery, W. Kim, Hedy L. Kindler, Hajime Asahina, M. Rosenberg, Mahmut Gumus, A. Pircher, A. López-González, N. Siddiqui, D. Torrejon Castro, V. Vilchez, R. Chacon, Dean A. Fennell, K. Umezawa, A. Szilagyi, T. Kojima, R. Mastico, Enriqueta Felip, Y. Zhang, P. Wheatley-Price, R. Guild, Rastilav Bahleda, D. Traphalis, M. Sergi, O. Ben Itzhak, T. Shibata, A.K. Patané, K. Das, S. Kumar, O. Vaisman, J. Stathopoulos, N. Yasar, W.M. Grogan, A. Soltermann, Steven G. Gray, H. Kang, J. Clince, M. Faehling, C.L. Hann, M. Barr, Lyudmila Bazhenova, B.G. Doger de Speville, A. Ruiz-Valdepeñas, Anne-Marie Baird, C. Kosmas, Y. Nakahara, T. Harada, J.D. Maltzman, M. Provencio Pulla, J. Parno, N. Yamamoto, M. Wollner, Antoine Hollebecque, David R. Spigel, Willi Oberaigner, Y. Kawai, M. Shibuya, E. Sari, E. Almagro-Casado, M. Mendez Garcia, N.J. Coleman, J. Raphael, Johanna C. Bendell, M. Fiegl, I. Opitz, G. Diaz, E. Jennions, Christophe Massard, G. Genestreti, M. Iguchi, P. Fatato

Publikováno v: Annals of Oncology. 23:ix492

Background Standard therapy for refractory or resistant relapsed small-cell lung cancer (SCLC) has not yet been established. We conducted an open-label, multicenter, non-randomized phase II study to confirm the efficacy and safety of amrubicin, a top

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3285e282bfecba0a422afa8f2b2c30d7
https://doi.org/10.1093/annonc/mds415

Zobrazit plný text záznamu

Pemetrexed and carboplatin in the treatment of malignant pleural mesothelioma (MPM)

Autor: M. Papi, G. Genestreti, D. Tassinari, E. Tamburini, S. Nicoletti, M. Nicolini, P. Fabbri, A. Santo, E. Pasquini, A. Ravaioli

Publikováno v: Journal of Clinical Oncology. 25:18114-18114

18114 Background. MPM is a poor prognosis disease, whose clinical negative outcome is due both to it’s aggressiveness and to the lack of active drugs for clinical practice. To assess activity and safety of pemetrexed-carboplatin combination in the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f5471dafbdaf05cdbe3a874d02a4b15f
https://doi.org/10.1200/jco.2007.25.18_suppl.18114

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání